Rezultati

eNauka >  Results >  Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial
Title: Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial
Authors : Grosicki, Sebastian; ...; Bila, Jelena S.  ; ...; (broj koautora 58)
Issue Date: 2020
Publication: Lancet
ISSN: 0140-6736 Lancet Search Idenfier
Publisher: London : Elsevier
Type: Article
Collation: vol. 396 br. 10262 str. 1563-1573
DOI: 10.1016/S0140-6736(20)32292-3
WoS-ID: 000588778800028
Scopus-ID: 2-s2.0-85096152969
PMID: 33189178
URI: https://enauka.gov.rs/handle/123456789/797056
URL: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32292-3/abstract
Project: Karyopharm Therapeutics
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

295
SCOPUSTM
165
PubMed CentralTM
92
OpenCitations
272
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.